This dataset provides ongoing reporting of confirmed (PCR) DC-resident COVID-19 positive cases. These data are dependent on accurate and timely reporting of COVID-19 positive cases by lab facilities. Data are presented by week of test collection; data show Sunday through Saturday of the same week. These data are subject to change on a weekly basis depending on lab facility reporting timelines and other factors. Data Sources: DC Health Notifiable Disease Surveillance System.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. More information available at https://coronavirus.dc.gov.Data for overall Coronavirus cases and testing results. Demographics are presented by race, gender, ethnicity and age. Additional variables for personnel in the public safety, medical and human service workforce. District agencies are Metropolitan Police Department (MPD), Fire and Emergency Medical Services (FEMS), Department of Corrections (DOC), Department of Youth Rehabilitation Services (DYRS) and Department of Human Services (DHS). Data for Saint Elizabeth's Hospital available. DYRS, DOC and DHS further report on its resident populations. Visit https://coronavirus.dc.gov/page/coronavirus-data for interpretation analysis.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. More information available at https://coronavirus.dc.gov. District of Columbia Department of Correction, both personnel and resident, testing for the number of positive tests, quarantined, returned to work, recovery and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

District of Columbia COVID-19 positive cases and total tests reported by Ward. Due to rapidly changing nature of COVID-19, data for March 2020 is limited. General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. District of Columbia Metropolitan Police Department testing for the number of positive tests, quarantined, returned to work and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

District of Columbia COVID-19 positive cases reported by DC Health Planning Neighborhoods. Due to rapidly changing nature of COVID-19, data for March 2020 is limited. General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. More information available at https://coronavirus.dc.gov. District of Columbia Department of Disability Services testing for the number of positive tests, quarantined, returned to work and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. More information available at https://coronavirus.dc.gov. District of Columbia Child and Family Services Agency testing for the number of positive tests, quarantined, returned to work and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. The data in this table includes overall COVID-19 statistics for the District of Columbia hospitals. The number of hospital beds and ventilators available. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance Data during a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. District of Columbia Department of Human Services testing for the number of positive tests, quarantined, returned to work and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. District of Columbia Public Schools testing for the number of positive tests and quarantined. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. District of Columbia Department of Youth Rehabilitation Services, both personnel and resident, testing for the number of positive tests, quarantined, returned to work, recovery and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. District of Columbia Office of Unified Communications testing for the number of positive tests, quarantined, returned to work and lives lost. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

United States COVID-19: No. of States incl Washington DC w/ Confirmed Cases data was reported at 51.000 Unit in 16 May 2023. This stayed constant from the previous number of 51.000 Unit for 15 May 2023. United States COVID-19: No. of States incl Washington DC w/ Confirmed Cases data is updated daily, averaging 51.000 Unit from Jan 2020 (Median) to 16 May 2023, with 1228 observations. The data reached an all-time high of 51.000 Unit in 16 May 2023 and a record low of 1.000 Unit in 21 Jan 2020. United States COVID-19: No. of States incl Washington DC w/ Confirmed Cases data remains active status in CEIC and is reported by CEIC Data. The data is categorized under High Frequency Database’s Disease Outbreaks – Table US.D001: Center for Disease Control and Prevention: Coronavirus Disease 2019 (COVID-2019).

SummaryThe cumulative number of COVID-19 vaccines distributed in Maryland.DescriptionThe MD COVID-19 - Total Doses Distributed Statewide data layer is a collection of the statewide COVID-19 vaccines that have been reported into VTrckS. Doses distributed also account for doses of vaccine provided to the District of Columbia to vaccinate Maryland residents who work in DC.COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138

On March 2, 2022 DC Health announced the District’s new COVID-19 Community Level key metrics and reporting. COVID-19 cases are now reported on a weekly basis. District of Columbia Department of Motor Vehicles testing for the number of positive tests, quarantined, returned to work and deaths. Due to rapidly changing nature of COVID-19, data for March 2020 is limited.General Guidelines for Interpreting Disease Surveillance DataDuring a disease outbreak, the health department will collect, process, and analyze large amounts of information to understand and respond to the health impacts of the disease and its transmission in the community. The sources of disease surveillance information include contact tracing, medical record review, and laboratory information, and are considered protected health information. When interpreting the results of these analyses, it is important to keep in mind that the disease surveillance system may not capture the full picture of the outbreak, and that previously reported data may change over time as it undergoes data quality review or as additional information is added. These analyses, especially within populations with small samples, may be subject to large amounts of variation from day to day. Despite these limitations, data from disease surveillance is a valuable source of information to understand how to stop the spread of COVID19.

This case surveillance public use dataset has 19 elements for all COVID-19 cases shared with CDC and includes demographics, geography (county and state of residence), any exposure history, disease severity indicators and outcomes, and presence of any underlying medical conditions and risk behaviors. Currently, CDC provides the public with three versions of COVID-19 case surveillance line-listed data: this 19 data element dataset with geography, a 12 data element public use dataset, and a 32 data element restricted access dataset. The following apply to the public use datasets and the restricted access dataset: - Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf. - Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers. - Some data are suppressed to protect individual privacy. - Datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the previously updated datasets. This 14-day lag allows case reporting to be stabilized and ensure that time-dependent outcome data are accurately captured. - Datasets are updated monthly. - Datasets are created using CDC’s Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy. - For more information about data collection and reporting, please see wwwn.cdc.gov/nndss/data-collection.html. - For more information about the COVID-19 case surveillance data, please see www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html. Overview The COVID-19 case surveillance database includes patient-level data reported by U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as "immediately notifiable, urgent (within 24 hours)" by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020 to clarify the interpretation of antigen detection tests and serologic test results within the case classification (Interim-20-ID-02). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data collected by jurisdictions are shared voluntarily with CDC. For more information, visit: wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/08/05/. COVID-19 Case Reports COVID-19 case reports are routinely submitted to CDC by pu

The United States remains the epicenter for the COVID-19 pandemic. Having accurate data reporting and analysis at the local, state, and national levels would help steer containment efforts, build a more targeted response strategy, and foster learnings across cities and states as new hotspots arise. Throughout the course of the pandemic, Population Council researchers have been tracking how COVID-19 data are reported and analyzed using a comprehensive analysis of 62 COVID-19 data sources from the Centers for Disease Control and Prevention (CDC) and health departments across 50 states, Washington D.C., and ten major cities. We assessed data completeness for COVID-19 testing and four outcomes (cases, hospitalizations, recoveries, and deaths), and examined disaggregation of COVID-19 testing and outcomes by a core set of demographic indicators, including age, race/ethnicity, sex/gender, geography, and underlying health conditions. This analysis also investigated how social and community level data were reported and analyzed, variations in data reporting, and changes over the course of the pandemic. Having this information can equip national and local health officials to deploy a more targeted response effort such as testing, contact tracing, treatment, and containment strategy.